Literature DB >> 396544

A study of the caeruloplasmin concentrations found in 75 patients with Wilson's disease, their kinships and various control groups.

K Gibbs, J M Walshe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 396544

Source DB:  PubMed          Journal:  Q J Med        ISSN： 0033-5622


× No keyword cloud information.
  13 in total

1.  Adjusting copper concentrations for caeruloplasmin levels in routine clinical practice.

Authors:  P J Twomey; A Viljoen; I M House; T M Reynolds; A S Wierzbicki
Journal:  J Clin Pathol       Date:  2006-04-27       Impact factor: 3.411

2.  Predicting genotypes at loci for autosomal recessive disorders using linked genetic markers: application to Wilson's disease.

Authors:  L A Farrer; B Bonne-Tamir; M Frydman; A Magazanik; K K Kidd; A M Bowcock; L L Cavalli-Sforza
Journal:  Hum Genet       Date:  1988-06       Impact factor: 4.132

3.  Molecular studies of ceruloplasmin deficiency in Wilson's disease.

Authors:  M J Czaja; F R Weiner; S J Schwarzenberg; I Sternlieb; I H Scheinberg; D H Van Thiel; N F LaRusso; M A Giambrone; R Kirschner; M L Koschinsky
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

4.  Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study.

Authors:  U Merle; M Schaefer; P Ferenci; W Stremmel
Journal:  Gut       Date:  2006-05-18       Impact factor: 23.059

Review 5.  Diagnosis and treatment of Wilson's disease.

Authors:  Indu Subramanian; Zeba F Vanek; Jeff M Bronstein
Journal:  Curr Neurol Neurosci Rep       Date:  2002-07       Impact factor: 5.081

Review 6.  Diagnosis of inherited metabolic disorders affecting the nervous system.

Authors:  P D Swanson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-11       Impact factor: 10.154

7.  Biomarkers for diagnosis of Wilson's disease.

Authors:  Aidan Ryan; Sarah J Nevitt; Orla Tuohy; Paul Cook
Journal:  Cochrane Database Syst Rev       Date:  2019-11-19

8.  Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia.

Authors:  Alan Zanardi; Antonio Conti; Marco Cremonesi; Patrizia D'Adamo; Enrica Gilberti; Pietro Apostoli; Carlo Vittorio Cannistraci; Alberto Piperno; Samuel David; Massimo Alessio
Journal:  EMBO Mol Med       Date:  2018-01       Impact factor: 12.137

9.  Ceruloplasmin and superoxide dismutase (SOD1) in heterozygotes for Wilson disease: A case control study.

Authors:  Gudlaug Tórsdóttir; Grétar Gudmundsson; Jakob Kristinsson; Jón Snaedal; Torkell Jóhannesson
Journal:  Neuropsychiatr Dis Treat       Date:  2009-04-08       Impact factor: 2.570

10.  Presentation, diagnosis and outcome of predominantly hepatic Wilson's disease in adult Saudi patients: a single centre experience.

Authors:  Ibrahim Altraif; Fayaz A Handoo; Hamdan Al Ghamdi; Abdulrahman Aljumah; Mohammed Al Jumah; Mohammed Afzal
Journal:  Saudi J Gastroenterol       Date:  2012 Sep-Oct       Impact factor: 2.485
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.